Spectral AI announced Tuesday it has secured a new contract with the Defense Health Agency (DHA) and the US Army Medical Material Development Activity (USAMMDA).
Spectral AI Scores New $500,000 Contract
The AI medical diagnostics company said the contract, valued at over $500,000, will directly support the development of the DeepView SnapShot M, a handheld version of Spectral AI’s DeepView Wound Imaging System. Designed for battlefield use, the DeepView SnapShot M aims to provide medical personnel with a portable and efficient tool for wound assessment.
This latest award brings the total government funding for the DeepView SnapShot M to over $6 million. The focus of the contract lies in optimising the device’s functionality and size while ensuring its durability and effectiveness in combat settings.
“Spectral AI is proud to partner with DHA and the USAMMDA on this crucial initiative,” stated Pete Carlson, CEO of Spectral AI. “This award further validates Spectral AI’s technology and the importance of a battlefield burn solution we are focusing on.”
Carlson further emphasised the broader impact of the collaboration, saying the miniaturisation of medical devices is key to expanding access to innovative healthcare across diverse clinical settings and for a wider range of patients.
“This development reaffirms Spectral AI’s dedication to shaping the future of accessible medical care and solidifies its position as a trailblazer in AI-driven healthcare innovation,” Carlson further noted.
Spectral Stock Rose Over 22%
Spectral AI has a history of receiving significant financial backing from the US government. This latest contract adds to the over $250 million already secured, including $149 million awarded in the past six months.
The news of the government contract was met positively by the market. Shares of Spectral AI rose 22.7% to $2.11 shortly before the opening bell on Tuesday.
